Inventor · disambiguated record
Neta Rosenzweig
Also filed as: ROSENZWEIG NETA
20 granted patents·5 pending applications·292 citations·filing 2013–2023
96Inventor score
Files withYEDA RES & DEV25
Top patents by PatentIndex Score
25 records- 0198US9534052B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2016·Granted Jan 3, 2017·24 cites·35 claims
- 0298US9512227B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2016·Granted Dec 6, 2016·23 cites·32 claims
- 0398US9512225B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2016·Granted Dec 6, 2016·25 cites·30 claims
- 0498US9394365B1Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's diseaseYEDA RES & DEV·Filed 2015·Granted Jul 19, 2016·62 cites·30 claims
- 0597US10144778B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2015·Granted Dec 4, 2018·24 cites·26 claims
- 0697US9856318B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2015·Granted Jan 2, 2018·22 cites·26 claims
- 0796US10214585B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2015·Granted Feb 26, 2019·14 cites·21 claims
- 0896US9982048B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 0996US9982050B2Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 1096US9982047B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 1196US9982049B2Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 1296US9982051B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·20 claims
- 1395US10618963B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2017·Granted Apr 14, 2020·10 cites·20 claims
- 1495US10519237B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2016·Granted Dec 31, 2019·10 cites·30 claims
- 1593US11492405B2Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2019·Granted Nov 8, 2022·4 cites·20 claims
- 1692US11643464B2Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorderYEDA RES & DEV·Filed 2019·Granted May 9, 2023·5 cites·17 claims
- 1792US10981989B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2019·Granted Apr 20, 2021·5 cites·18 claims
- 1890US11884728B2Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosisYEDA RES & DEV·Filed 2021·Granted Jan 30, 2024·1 cites·21 claims
- 1990US11884727B2Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosisYEDA RES & DEV·Filed 2021·Granted Jan 30, 2024·1 cites·23 claims
- 2089US2024182566A1Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNSYEDA RES & DEV·Filed 2023·Application pending·0 cites
- 2187US10961309B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2018·Granted Mar 30, 2021·2 cites·24 claims
- 2273US2023183350A1Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNSYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 2358US2015238582A1Individualized immunomodulation therapy for neurodegenerative disorders, cns injury and age-related dementiaYEDA RES & DEV·Filed 2013·Application pending·0 cites
- 2453US2019022198A1Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related DementiaYEDA RES & DEV·Filed 2018·Application pending·0 cites
- 2551US2022146534A1Biomarkers for CNS Disease ModificationYEDA RES & DEV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neta Rosenzweig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →